RSP vs SCHD
Invesco S&P 500 Equal Weight ETF vs Schwab US Dividend Equity ETF
- • SCHD has the lower expense ratio at 0.06% vs 0.20% for RSP.
- • SCHD pays a higher dividend yield (3.30%).
Side-by-side metrics
| Metric | RSP | SCHD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.20% | 0.06% |
Dividend yield Trailing 12-month yield. | 1.51% | 3.30% |
AUM Assets under management — bigger funds are typically more liquid. | $93.66B | $95.73B |
YTD return | 11.67% | 19.84% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.85 | 0.58 |
P/E ratio | 22.11 | 18.61 |
Last price | $213.50 | $32.26 |
Inception | — | — |
Issuer | Invesco | Schwab |
RSP top holdings
| MRNA | Moderna Inc | 0.29% |
| GLW | Corning Inc | 0.29% |
| AMAT | Applied Materials Inc | 0.28% |
| KLAC | KLA Corp | 0.27% |
| TER | Teradyne Inc | 0.27% |
| SNDK | SanDisk Corp Ordinary Shares | 0.27% |
| GEV | GE Vernova Inc | 0.26% |
| LRCX | Lam Research Corp | 0.26% |
| TECH | Bio-Techne Corp | 0.26% |
| UAL | United Airlines Holdings Inc | 0.26% |
SCHD top holdings
| MRK | Merck & Co Inc | 4.52% |
| HD | The Home Depot Inc | 4.49% |
| UNH | UnitedHealth Group Inc | 4.46% |
| AMGN | Amgen Inc | 4.27% |
| ABT | Abbott Laboratories | 4.27% |
| PG | Procter & Gamble Co | 4.25% |
| KO | Coca-Cola Co | 4.21% |
| PEP | PepsiCo Inc | 3.90% |
| VZ | Verizon Communications Inc | 3.79% |
| TXN | Texas Instruments Inc | 3.71% |
About RSP
RSP (Invesco S&P 500 Equal Weight ETF) is S&P 500 with each stock equally weighted. Managed by Invesco, the fund carries $93.7B in assets under management, an expense ratio of 0.20%, a dividend yield of 1.51%. Its largest holding is Moderna Inc (MRNA), which represents 0.3% of the portfolio. Real Estate is the fund's largest sector exposure at 5.9%.
About SCHD
SCHD (Schwab US Dividend Equity ETF) is High-quality US dividend-paying stocks. Managed by Schwab, the fund carries $95.7B in assets under management, an expense ratio of 0.06%, a dividend yield of 3.30%. Its largest holding is Merck & Co Inc (MRK), which represents 4.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 7.7%.